Biocon, Quark get DCGI nod for trials of new eye disease drug 00:08 andrey Без рубрики No comments Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy." Share This: Facebook Twitter Google+ Stumble Digg Отправить по электронной почтеНаписать об этом в блогеПоделиться в XОпубликовать в Facebook Related Posts:'KP's book is the biggest work of fiction since Jules Verne'Former England team mate Graeme Swann began the backlash against Kevin Pietersen's new book on Monday by labelling it "the biggest work of fiction sin… Read MoreWoakes helps England crush Windies in World Cup warm-upChris Woakes took 5 for 19 as England claimed a comfortable nine-wicket victory in their first official World Cup warm-up match after dismissing a hap… Read MoreICC RANKINGS: India hold on to No 2 spot; Kohli at No 3Virat Kohli and Bhuvneshwar Kumar are India's highest-ranked batsman and bowler in third and 13th positions respectively.… Read MoreAbbott bounces back, takes two wickets on return to SCGAustralian bowler Sean Abbott returned to action with New South Wales.… Read MoreOdisha CM orders probe into second T20 fiasco at CuttackExpressing displeasure over the manner in which the organisers handled the second T20 cricket match between India and South Africa at Cuttack, Odisha … Read More
0 коммент.:
Отправить комментарий